Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy
暂无分享,去创建一个
T. Chan | Hang Li | Y. Wen | Xue-wang Li | Xue-mei Li | C. Tang | D. Yap | G. Chan | Chao Li | Xuewang Li
[1] M. M. Mok,et al. Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years , 2017, The Journal of Rheumatology.
[2] J. Alcocer-Varela,et al. Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes A Case-Control Study , 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[3] R. Correa-Rotter,et al. Renal flare prediction and prognosis in lupus nephritis Hispanic patients , 2016, Lupus.
[4] J. Alcocer-Varela,et al. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. , 2014, Thrombosis research.
[5] Su-xia Wang,et al. Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China , 2014, TheScientificWorldJournal.
[6] Y. Fukasawa,et al. Long-term outcome in Japanese patients with lupus nephritis , 2014, Lupus.
[7] Xiangpei Li,et al. Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus , 2014, Journal of immunology research.
[8] H. Nagaraja,et al. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[9] T. Yao,et al. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus – a 20-year experience in Asia , 2013, Lupus.
[10] Su-xia Wang,et al. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. , 2013, Kidney international.
[11] M. K. Ma,et al. Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis. , 2013, Rheumatology.
[12] Min Chen,et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis , 2013, Arthritis Research & Therapy.
[13] M. Lam,et al. Survival analysis and causes of mortality in patients with lupus nephritis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] S. Cohney,et al. Thrombotic microangiopathy and associated renal disorders* , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] D. Gladman,et al. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[16] Namhee Kwon,et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality , 2012, Arthritis care & research.
[17] C. Mohan,et al. Lupus nephritis: current update , 2011, Arthritis research & therapy.
[18] Y. C. Kim,et al. The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis , 2011, Lupus.
[19] Ming-Huang Chen,et al. Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan. , 2011, Rheumatology.
[20] D. Gipson,et al. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[21] D. Isenberg,et al. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study , 2009, Rheumatology.
[22] S. Shinjo,et al. Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus , 2009, Clinical Rheumatology.
[23] D. Isenberg,et al. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. , 2006, Rheumatology.
[24] E. Mannarino,et al. Precocious intima-media thickening in patients with primary Sjögren's syndrome. , 2005, Arthritis and rheumatism.
[25] M. Bennett,et al. Role of apoptosis in atherosclerosis and its therapeutic implications. , 2004, Clinical science.
[26] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.
[27] E. Donadi,et al. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations , 2002, Journal of Neurology.
[28] G. Illei,et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. , 2002, Arthritis and rheumatism.
[29] T. Chan,et al. Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis , 2000 .
[30] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[31] D. Droz,et al. Renal vascular lesions in lupus nephritis. , 1997, Medicine.
[32] M. Hughson,et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] G. Mazzucco,et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] V. Jha,et al. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. , 2016, Kidney international.
[35] C. Lau,et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. , 2000, The New England journal of medicine.
[36] M. Kinjo,et al. Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus. , 1985, Human pathology.